a 63162 has been researched along with 16,16-dimethylprostaglandin e2 in 1 studies
| Studies (a 63162) | Trials (a 63162) | Recent Studies (post-2010) (a 63162) | Studies (16,16-dimethylprostaglandin e2) | Trials (16,16-dimethylprostaglandin e2) | Recent Studies (post-2010) (16,16-dimethylprostaglandin e2) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 542 | 22 | 14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehrlich, K; Peskar, BA; Peskar, BM; Schuligoi, R | 1 |
1 other study(ies) available for a 63162 and 16,16-dimethylprostaglandin e2
| Article | Year |
|---|---|
Role of lipoxygenases and the lipoxin A(4)/annexin 1 receptor in ischemia-reperfusion-induced gastric mucosal damage in rats.
Topics: 16,16-Dimethylprostaglandin E2; Acetamides; Animals; Annexins; Anti-Ulcer Agents; Celecoxib; Cyclooxygenase Inhibitors; Dexamethasone; Drug Synergism; Flavanones; Fluorenes; Gastric Mucosa; Glucocorticoids; Indoles; Indomethacin; Lipoxygenase; Lipoxygenase Inhibitors; Male; Oligopeptides; Phenyl Ethers; Prostaglandin Antagonists; Pyrazoles; Rats; Rats, Wistar; Receptors, Formyl Peptide; Receptors, Lipoxin; Reperfusion Injury; Sulfonamides | 2009 |